Non-HACEK gram-negative bacillus endocarditis

Fowler Jr. V.G.; Morpeth S.; Murdoch D.; Cabell C.H.; Corey G.R.; Karchmer A.W.; Pappas P.; Levine, D; Nacinovich, F; Tattevin, P; Fernandez-Hidalgo N.; Dickerman S.; Bouza, E; Del Rio A.; Lejko-Zupanc T.; et. al.

Keywords: heart, bacteria, infections, intravenous, infection, mortality, identification, care, risk, disease, trial, implant, implants, treatment, abuse, bacterial, multicenter, surgery, humans, endocarditis, human, male, agents, pseudomonas, aged, health, agent, outcome, adult, female, coli, drug, cohort, data, article, bacterium, factor, microbiology, base, analysis, cross, hospitalization, assessment, follow, surgical, prostheses, clinical, studies, cardiac, aeruginosa, study, substance, priority, nonhuman, journal, up, major, and, Escherichia, prospective, antiinfective, Anti-Bacterial, Community-Acquired, gram, negative, Procedures, Gram-Negative, Endocarditis,, communicable, Abuse,, iatrogenic, orthoses

Abstract

Background: Infective endocarditis caused by non-HACEK (species other than Haemophilus species, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, or Kingella species) gram-negative bacilli is rare, is poorly characterized, and is commonly considered to be primarily a disease of injection drug users. Objective: To describe the clinical characteristics and outcomes of patients with non-HACEK gram-negative bacillus endocarditis in a large, international, contemporary cohort of patients. Design: Observations from the International Collaboration on Infective Endocarditis Prospective Cohort Study (ICE-PCS) database. Setting: 61 hospitals in 28 countries. Patients: Hospitalized patients with definite endocarditis. Measurements: Characteristics of non-HACEK gram-negative bacillus endocarditis cases were described and compared with those due to other pathogens. Results: Among the 2761 case-patients with definite endocarditis enrolled in ICE-PCS, 49 (1.8%) had endocarditis (20 native valve, 29 prosthetic valve or device) due to non-HACEK, gram-negative bacilli. Escherichia coli (14 patients [29%]) and Pseudomonas aeruginosa (11 patients [22%]) were the most common pathogens. Most patients (57%) with non-HACEK gram-negative bacillus endocarditis had health care-associated infection, whereas injection drug use was rare (4%). Implanted endovascular devices were frequently associated with non-HACEK gram-negative bacillus endocarditis compared with other causes of endocarditis (29% vs. 11%; P < 0.001). The in-hospital mortality rate of patients with endocarditis due to non-HACEK gram-negative bacilli was high (24%) despite high rates of cardiac surgery (51%). Limitations: Because of the small number of patients with non-HACEK gram-negative bacillus endocarditis in each treatment group and the lack of long-term follow-up, strong treatment recommendations are difficult to make. Conclusion: In this large, prospective, multinational cohort, more than one half of all cases of non-HACEK gram-negative bacillus endocarditis were associated with health care contact. Non-HACEK gram-negative bacillus endocarditis is not primarily a disease of injection drug users. © 2007 American College of Physicians.

Más información

Título según SCOPUS: Non-HACEK gram-negative bacillus endocarditis
Título de la Revista: ANNALS OF INTERNAL MEDICINE
Volumen: 147
Número: 12
Editorial: AMER COLL PHYSICIANS
Fecha de publicación: 2007
Página de inicio: 829
Página final: 835
Idioma: eng
URL: http://www.scopus.com/inward/record.url?eid=2-s2.0-38449122050&partnerID=q2rCbXpz
Notas: SCOPUS